{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:24:00Z","timestamp":1765545840773},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T00:00:00Z","timestamp":1379548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s40520-013-0106-x","type":"journal-article","created":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T05:58:53Z","timestamp":1379483933000},"page":"117-119","source":"Crossref","is-referenced-by-count":5,"title":["New therapeutical horizons in the management of postmenopausal osteoporosis"],"prefix":"10.1007","volume":"25","author":[{"given":"Silvia","family":"Migliaccio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachele","family":"Fornari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela A.","family":"Greco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Di Luigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,19]]},"reference":[{"key":"106_CR1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0889-857X(05)70197-6","volume":"27","author":"DT Gold","year":"2001","unstructured":"Gold DT (2001) The nonskeletal consequences of osteoporotic fractures. Psychologic and social outcomes. Rheum Dis Clin North Am 27:255\u2013262","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"106_CR2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/ciia.2007.2.1.55","volume":"2","author":"S Migliaccio","year":"2007","unstructured":"Migliaccio S, Brama M, Spera G (2007) The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis. Clin Interv Aging 2(1):55\u201364","journal-title":"Clin Interv Aging"},{"key":"106_CR3","first-page":"S20","volume":"3","author":"S Migliaccio","year":"2004","unstructured":"Migliaccio S, Falcone S, Spera G (2004) Bone modelling and remodelling: from biology to clinical application. Aging Clin Exp Res 3:S20\u2013S22","journal-title":"Aging Clin Exp Res"},{"issue":"S5","key":"106_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-003-1465-5","volume":"14","author":"E Seeman","year":"2003","unstructured":"Seeman E (2003) Bone quality. Osteoporos Int 14(S5):3\u20137","journal-title":"Osteoporos Int"},{"issue":"4","key":"106_CR5","first-page":"260","volume":"61","author":"S Adami","year":"2009","unstructured":"Adami S, Bertoldo F, Brandi ML, SIOMMMS et al (2009) Guidelines for the diagnosis, prevention and treatment of osteoporosis. Reumatismo 61(4):260\u2013284","journal-title":"Reumatismo"},{"issue":"Suppl","key":"106_CR6","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0378-5122(02)00145-7","volume":"43","author":"A Diez-Perez","year":"2002","unstructured":"Diez-Perez A (2002) Bisphosphonates. Maturitas 43(Suppl):S19\u2013S26","journal-title":"Maturitas"},{"key":"106_CR7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S8756-3282(01)00685-8","volume":"30","author":"A Taranta","year":"2002","unstructured":"Taranta A, Brama M et al (2002) The selective estrogen receptor modulator Raloxifene modulates osteoblast and osteoclast activity in vitro. Bone 30:365\u2013376","journal-title":"Bone"},{"key":"106_CR8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","volume":"282","author":"B Ettinger","year":"1999","unstructured":"Ettinger B, Black DM et al (1999) Reduction of vertebral fracture risk in post menopausal women with osteoporosis treated with raloxifene. Results from a 3-year randomized clinical trial. JAMA 282:637\u2013645","journal-title":"JAMA"},{"key":"106_CR9","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.2165\/0003495-200868180-00012","volume":"68","author":"SD Blick","year":"2008","unstructured":"Blick SD, Dhillon S, Keam SJ (2008) Teriparatide: a review of its use in osteoporosis. Drugs 68:2709\u20132737","journal-title":"Drugs"},{"key":"106_CR10","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD et al (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in post-menopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"106_CR11","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra067395","volume":"357","author":"E Canalis","year":"2007","unstructured":"Canalis E, Giustina A, Bilezikian JP (2007) Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 357:905\u2013916","journal-title":"N Engl J Med"},{"key":"106_CR12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MED.0b013e32831a46d6","volume":"15","author":"F Cosman","year":"2008","unstructured":"Cosman F (2008) Parathyroid hormone treatment for osteoporosis. Curr Opin Endocrinol Diabetes Obes 15:495\u2013501","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"106_CR13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF03344081","volume":"29","author":"BL Wang","year":"2006","unstructured":"Wang BL, Dai CL et al (2006) Parathyroid hormone regulates osterix and Runx2 mRNA expression predominantly through protein kinase A signalling in osteoblast-like cells. J Endocrinol Investig 29:101\u2013108","journal-title":"J Endocrinol Investig"},{"key":"106_CR14","doi-asserted-by":"crossref","first-page":"10856","DOI":"10.1074\/jbc.M513380200","volume":"281","author":"D Gesty-Palmer","year":"2006","unstructured":"Gesty-Palmer D, Chen M et al (2006) Distinct beta-arrestin and G-protein-dependent pathways for parathyroid hormone receptor-stimulated ERK \u00bd activation. J Biol Chem 281:10856\u201310864","journal-title":"J Biol Chem"},{"key":"106_CR15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/8756-3282(95)00427-0","volume":"18","author":"M Sabatini","year":"1996","unstructured":"Sabatini M, Lesur C et al (1996) Effects of parathyroid hormone and agonists of the adenylyl cyclase and protein kinase C pathways on bone cell proliferation. Bone 18:59\u201365","journal-title":"Bone"},{"issue":"8","key":"106_CR16","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2106\/JBJS.L.00285","volume":"95","author":"MS Virk","year":"2013","unstructured":"Virk MS, Alaee F et al (2013) Systemic administration of sclerostin antibody enhances bone repair in a critical-sized femoral defect in a rat model. J Bone Joint Surg Am 95(8):694\u2013701","journal-title":"J Bone Joint Surg Am"},{"key":"106_CR17","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Shima N et al (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc Natl Acad Sci USA 95:3597\u20133602","journal-title":"Proc Natl Acad Sci USA"},{"key":"106_CR18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2174\/1381612013397807","volume":"7","author":"PJ Kostenuik","year":"2001","unstructured":"Kostenuik PJ, Shalhoub V (2001) Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption. Curr Pharm Des 7:613\u2013635","journal-title":"Curr Pharm Des"},{"key":"106_CR19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1083\/jcb.145.3.527","volume":"145","author":"TL Burgess","year":"1999","unstructured":"Burgess TL, Quian Y et al (1999) The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol 145:527\u2013538","journal-title":"J Cell Biol"},{"issue":"2","key":"106_CR20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1210\/jc.2012-2972","volume":"98","author":"K Brixen","year":"2013","unstructured":"Brixen K, Chapurlat R et al (2013) Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial. JCEM 98(2):571\u2013580","journal-title":"JCEM"},{"key":"106_CR21","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/jbmr.1695","volume":"27","author":"B Langdahl","year":"2012","unstructured":"Langdahl B, Binkley N et al (2012) Odanacatib\u00a0in the treatment of postmenopausal women with low bone mineral density: five years of continued therapy in a phase 2 study. JBMR 27:2251\u20132258","journal-title":"JBMR"},{"key":"106_CR22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S8756-3282(02)00687-7","volume":"30","author":"RG Pereira","year":"2002","unstructured":"Pereira RG, Delany AM, Canalis E (2002) Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression. Bone 30:685\u2013691","journal-title":"Bone"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-013-0106-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40520-013-0106-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-013-0106-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T05:43:00Z","timestamp":1596519780000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40520-013-0106-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,19]]},"references-count":22,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["106"],"URL":"https:\/\/doi.org\/10.1007\/s40520-013-0106-x","relation":{},"ISSN":["1720-8319","1720-8319"],"issn-type":[{"value":"1720-8319","type":"print"},{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,19]]}}}